Journey Biosciences, Inc., a biotechnology company offering biomarker-based predictive risk screening technologies for diabetes-related complications, announced the launch of its flagship product NaviDKD.
NaviDKD, a...
NEOconcepts, a leading distributor of aesthetic medical devices for dermatologists, plastic surgeons, and other medical aesthetic providers, has signed an exclusive agreement with Triworks,...
The phase 3 trial results for lecanemab and gantenerumab presented at the Clinical Trials on Alzheimer's Disease (CTAD) conference demonstrate why optimal treatment of...
Esperovax, a leading developer of oral vaccines, announced it has signed a new, exclusive licensing agreement with Innovation Partners at the University of Michigan...
The U.S. Food and Drug Administration approved Rebyota, the first fecal microbiota product approved by the agency. Rebyota is approved for the prevention of...
